Abstract
The Conference on Retroviruses and Opportunistic Infections (CROI) 2015 took place February 23-26, 2015, in Seattle, Washington, and brought together researchers from around the world to share important developments and findings in the field of HIV Medicine and related infectious diseases. This report focuses on studies of new antiretroviral drugs and anti-hepatitis C virus therapies that were presented at CROI 2015.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 323-328 |
| Number of pages | 6 |
| Journal | Drugs of the Future |
| Volume | 40 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 1 2015 |
Keywords
- Asunaprevir
- Beclabuvir
- Cabotegravir
- Daclatasvir
- Dasabuvir
- Ledipasvir
- Ombitasvir
- Paritaprevir
- Sofosbuvir
- Tenofovir alafenamide fumarate
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)